StockIQpro
NASDAQ:HSCS

HeartSciences Inc.

Track all markets on TradingView
Track all markets on TradingView

HeartSciences Inc.'s revenue fell 0.7% in fiscal 2026 to $4,319. Return on average equity was −4239.9%.Summary generated from HeartSciences Inc.'s SEC filings. Latest annual report filed Jul 23, 2026.

Key statistics

Fiscal 2026 from SEC filings. Methodology
Revenue (FY26)$4,319
Revenue growth−0.7%
Revenue, 5-yr CAGRn/a
Net margin−211666.5%
Return on equity−4239.9%
Share count changen/a

Margin, ROIC, debt and free-cash-flow measures are not shown for banks and insurers, whose statements are not built around them.

Financials

Fiscal years, $M
Item20222023202420252026
Revenue00000
Net income−5−6−7−9−9

Recent filings

From SEC EDGAR

Peers

Finance services